2results about How to "Timely treatment" patented technology

This invention discloses a blood culture detection system based on spectral reflectance technology, comprising: a culture container for culturing samples; a sensor for sensing the sample state and changing color according to changes in the sample state; a light signal acquisition component for projecting single-wavelength light onto the sensor and receiving the reflected light signal after reflection by the sensor; and a reading module for obtaining a reading result indicating whether the sample is infected based on the received reflected light signal; the light source is used to project at least two different colors of single-wavelength light onto the sensor. This invention also discloses an alarm method for the blood culture detection system based on spectral reflectance technology. The blood culture detection system and alarm method of this invention, based on spectral reflectance technology, improve the accuracy of positive rate readings by using different wavelength light sources for detection.

The application discloses a biomarker for predicting unexplained recurrent spontaneous abortion and application thereof, and belongs to the technical field of molecular diagnosis and molecular biology. By comparing serum detection of 45 unexplained recurrent spontaneous abortion patients, it is found that the expression level of miR-142-3p in the serum of the unexplained recurrent spontaneous abortion patients is obviously higher than that of normal pregnant women. Compared with the normal pregnant women, the peripheral blood CD4 + CD25 + Treg cell level of the unexplained recurrent spontaneous abortion patients is significantly increased. By detecting the expression level of miR-142-3p, the unexplained recurrent spontaneous abortion patients can be pre-judged, so that the miR-142-3p can be used as an important index for clinically diagnosing and evaluating unexplained recurrent spontaneous abortion.